ELIG Capital

The principals and investment committee members of ELIG Capital are not identified in public records. The firm does not maintain a public LinkedIn profile or a disclosed team page on its website, which is typical for private Chinese investment firms that raise capital exclusively from domestic limited partners and do not market to foreign institutional allocators.

ELIG Capital operates across venture capital, growth equity, and buyouts under a single platform. This is structurally different from the standard Chinese private equity model, where firms typically launch separate fund families with distinct branding, teams, and limited partner rosters for each strategy. The unified structure implies a centralized investment committee and shared back-office functions.

Based on its described strategy, ELIG Capital executes direct investments across its target stages — from seed equity rounds to buyout control positions. There is no public indication that the firm acts as a fund-of-funds or commits capital to external managers. The firm's own characterization suggests it is exclusively a direct investor.

ELIG Capital has not publicly disclosed sector-specific investment mandates. Given its Beijing headquarters and multi-stage structure, the firm likely maintains a generalist approach with potential emphasis on sectors aligned with China's domestic economic priorities — technology, consumer, and healthcare — though this is inferential and not confirmed by the firm.

ELIG Capital does not disclose its limited partner base. As a Beijing-based private equity firm with no visible international marketing presence, its capital likely originates from domestic Chinese institutional investors, family offices, or high-net-worth individuals. The firm has not publicized any relationships with foreign pension funds, endowments, or sovereign wealth funds.